http://www.sciencemag.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug

President Donald Trump and Food and Drug Administration Commissioner Stephen Hahn (right) met with Daniel O’Day (left), the CEO of Gilead Sciences, when remdesivir received an emergency use authorization in May.

Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.